Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market^® (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SMon the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.